Le Lézard
Classified in: Health, Business

Welltower's Credit Rating Upgraded by S&P Global Ratings to 'A-' and by Moody's Investor Services to 'A3'


TOLEDO, Ohio, March 31, 2025 /PRNewswire/ -- Welltower Inc. (NYSE: WELL) (the "Company") today announced that S&P Global Ratings ("S&P") and Moody's Investor Service, Inc. ("Moody's") raised their credit ratings related to the Company to "A-" with a stable outlook and to "A3" with a stable outlook, respectively.

In its note, S&P cited Welltower's continued benefit from robust industry tailwinds and the material strengthening of its balance sheet as drivers of the ratings upgrade. S&P also expects strong operating performance to drive additional improvement to credit metrics over the next two years, driven by beneficial industry supply and demand dynamics along with Welltower's superior operating platform, providing a competitive advantage relative to peers.

Additionally, Moody's highlighted Welltower's improvement in leverage over the past year, partially driven by strong revenue and earnings growth. Moody's expects Welltower to benefit from an acceleration in the growth of the ageing population and an expansion in Welltower's addressable market, leading to the Company meeting or exceeding growth guidance and further strengthening its financial metrics.

"We are pleased with the recognition of Welltower's balance sheet strength and operational excellence by both S&P and Moody's," commented Tim McHugh, Welltower's Co-President and CFO.  "Alongside tactical funding of capital deployment, the improving fundamentals of our business have enabled us to deliver sector-leading per-share cash-flow growth to our shareholders, while also harnessing the power of the early part of the cyclical recovery to execute a historic deleveraging. The upgrades further enhance Welltower's industry leading access to capital and position us to continue capitalizing on long-term value accretive investment opportunities, including those in the Welltower Business System, our end-to-end operating platform."

About Welltower

Welltower® Inc. (NYSE: WELL) an S&P 500 company, is the world's preeminent residential wellness and healthcare infrastructure company. Our portfolio of 1,500+ Seniors and Wellness Housing communities is positioned at the intersection of housing, healthcare, and hospitality, creating vibrant communities for mature renters and older adults in the United States, United Kingdom, and Canada. We also seek to support physicians in our Outpatient Medical buildings with the critical infrastructure needed to deliver quality care.

Our real estate portfolio is unmatched, located in highly attractive micro-markets with stunning built environments. Yet, we are an unusual real estate organization as we view ourselves as a product company in a real estate wrapper driven by relationships and unconventional culture.

Through our disciplined approach to capital allocation powered by our data science platform and superior operating results driven by the Welltower Business System, we aspire to deliver long-term compounding of per share growth and returns for our existing investors ? our North Star.

 

SOURCE Welltower Inc.


These press releases may also interest you

at 07:45
OS Therapies ("OS Therapies" or "the Company"), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, today announced that the Company will be hosting an Analyst Day at the New York Stock Exchange in Lower...

at 07:30
Aurora Spine Corporation ("Aurora Spine" or the "Company") , a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the publication of a new clinical study titled "Fixation of the Sacroiliac...

at 07:30
Biogen Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to BIIB080, an investigational antisense oligonucleotide (ASO) therapy targeting tau, for the treatment of Alzheimer's disease. Fast...

at 07:10
RyCarma Therapeutics, Inc., a clinical-stage biotech company developing first-in-class small molecule therapeutics for cardiovascular and skeletal muscle diseases, has appointed Elizabeth Tarka, M.D., as its Chief Medical Officer (CMO). In this role,...

at 07:06
Quest Diagnostics , a leader in diagnostic information services, today announced a new solution aimed at broadening access to human papillomavirus (HPV) screening to help identify women who are at risk of developing cervical cancer....

at 07:05
KalVista Pharmaceuticals, Inc. , today announced that the compensation committee of KalVista's board of directors granted ten newly-hired employees inducement options to purchase an aggregate of 87,000 shares of KalVista common stock on April 1, 2025...



News published on and distributed by: